245 related articles for article (PubMed ID: 30011887)
1. Potential for Mitochondrial DNA Sequencing in the Differential Diagnosis of Gynaecological Malignancies.
Perrone AM; Girolimetti G; Procaccini M; Marchio L; Livi A; Borghese G; Porcelli AM; De Iaco P; Gasparre G
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011887
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial DNA genotyping efficiently reveals clonality of synchronous endometrial and ovarian cancers.
Guerra F; Girolimetti G; Perrone AM; Procaccini M; Kurelac I; Ceccarelli C; De Biase D; Caprara G; Zamagni C; De Iaco P; Santini D; Gasparre G
Mod Pathol; 2014 Oct; 27(10):1412-20. PubMed ID: 24633194
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial DNA genotyping reveals synchronous nature of simultaneously detected endometrial and ovarian cancers.
Guerra F; Kurelac I; Magini P; Cormio A; Santini D; Ceccarelli C; Gasparre G
Gynecol Oncol; 2011 Aug; 122(2):457-8. PubMed ID: 21592547
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial DNA sequencing demonstrates clonality of peritoneal implants of borderline ovarian tumors.
Girolimetti G; De Iaco P; Procaccini M; Panzacchi R; Kurelac I; Amato LB; Dondi G; Caprara G; Ceccarelli C; Santini D; Porcelli AM; Perrone AM; Gasparre G
Mol Cancer; 2017 Feb; 16(1):47. PubMed ID: 28241835
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY
Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
[TBL] [Abstract][Full Text] [Related]
6. [Study on the mitochondrion DNA mutation in tumor tissues of gynecologic oncology patients].
Li HX; Zhong S; Li CH
Zhonghua Fu Chan Ke Za Zhi; 2003 May; 38(5):290-3. PubMed ID: 12895314
[TBL] [Abstract][Full Text] [Related]
7. Lynch Syndrome: Female Genital Tract Cancer Diagnosis and Screening.
Mills AM; Longacre TA
Surg Pathol Clin; 2016 Jun; 9(2):201-14. PubMed ID: 27241104
[TBL] [Abstract][Full Text] [Related]
8. Microsatellite instability in mitochondrial genome of common female cancers.
Wang Y; Liu VW; Tsang PC; Chiu PM; Cheung AN; Khoo US; Nagley P; Ngan HY
Int J Gynecol Cancer; 2006; 16 Suppl 1():259-66. PubMed ID: 16515601
[TBL] [Abstract][Full Text] [Related]
9. Impact of gynecological screening in Lynch syndrome carriers with an MSH2 mutation.
Stuckless S; Green J; Dawson L; Barrett B; Woods MO; Dicks E; Parfrey PS
Clin Genet; 2013 Apr; 83(4):359-64. PubMed ID: 22775459
[TBL] [Abstract][Full Text] [Related]
10. A molecular genetic and statistical approach for the diagnosis of dual-site cancers.
Brinkmann D; Ryan A; Ayhan A; McCluggage WG; Feakins R; Santibanez-Koref MF; Mein CA; Gayther SA; Jacobs IJ
J Natl Cancer Inst; 2004 Oct; 96(19):1441-6. PubMed ID: 15467033
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial DNA analysis efficiently contributes to the identification of metastatic contralateral breast cancers.
Girolimetti G; Marchio L; De Leo A; Mangiarelli M; Amato LB; Zanotti S; Taffurelli M; Santini D; Gasparre G; Ceccarelli C
J Cancer Res Clin Oncol; 2021 Feb; 147(2):507-516. PubMed ID: 33236215
[TBL] [Abstract][Full Text] [Related]
12. Implication of genomic characterization in synchronous endometrial and ovarian cancers of endometrioid histology.
Chao A; Wu RC; Jung SM; Lee YS; Chen SJ; Lu YL; Tsai CL; Lin CY; Tang YH; Chen MY; Huang HJ; Chou HH; Huang KG; Chang TC; Wang TH; Lai CH
Gynecol Oncol; 2016 Oct; 143(1):60-67. PubMed ID: 27498588
[TBL] [Abstract][Full Text] [Related]
13. [Circulating tumor DNA assessment for gynaecological cancers management].
Mari R; Lambaudie É; Provansal M; Sabatier R
Bull Cancer; 2019 Mar; 106(3):237-252. PubMed ID: 30765097
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor markers in gynecological tumors.
Rustin GJ
Curr Opin Oncol; 1996 Sep; 8(5):426-31. PubMed ID: 8914810
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA and gynecologic cancers.
Kanekura K; Nishi H; Isaka K; Kuroda M
J Obstet Gynaecol Res; 2016 Jun; 42(6):612-7. PubMed ID: 27098274
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial D310 mutation as clonal marker for solid tumors.
Geurts-Giele WR; Gathier GH; Atmodimedjo PN; Dubbink HJ; Dinjens WN
Virchows Arch; 2015 Nov; 467(5):595-602. PubMed ID: 26276353
[TBL] [Abstract][Full Text] [Related]
17. [Synchronous associations of tumors in the pelvic organs of the female genital tract].
Carta G; Porzio G; Toro G; Moscarini M
Minerva Ginecol; 1992 Sep; 44(9):415-8. PubMed ID: 1436613
[TBL] [Abstract][Full Text] [Related]
18. Molecular diagnosis and prognosis in gynecologic oncology.
Silverberg SG
Arch Pathol Lab Med; 1999 Nov; 123(11):1035-40. PubMed ID: 10539903
[TBL] [Abstract][Full Text] [Related]
19. The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas.
Furlan D; Carnevali I; Marcomini B; Cerutti R; Dainese E; Capella C; Riva C
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3329-36. PubMed ID: 16740754
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide single nucleotide polymorphism arrays as a diagnostic tool in patients with synchronous endometrial and ovarian cancer.
Ikeda Y; Oda K; Nakagawa S; Murayama-Hosokawa S; Yamamoto S; Ishikawa S; Wang L; Takazawa Y; Maeda D; Wada-Hiraike O; Kawana K; Fukayama M; Aburatani H; Yano T; Kozuma S; Taketani Y
Int J Gynecol Cancer; 2012 Jun; 22(5):725-31. PubMed ID: 22635024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
